Authors
Paddy Ssentongo, Anna E Ssentongo, Navya Voleti, Destin Groff, Ashley Sun, Djibril M Ba, Jonathan Nunez, Leslie J Parent, Vernon M Chinchilli, Catharine I Paules
Publication date
2022/5/7
Source
BMC infectious diseases
Volume
22
Issue
1
Pages
439
Publisher
BioMed Central
Description
Background
The temporal evolution of SARS-CoV-2 vaccine efficacy and effectiveness (VE) against infection, symptomatic, and severe COVID-19 is incompletely defined. The temporal evolution of VE could be dependent on age, vaccine types, variants of the virus, and geographic region. We aimed to conduct a systematic review and meta-analysis of the duration of VE against SARS-CoV-2 infection, symptomatic COVID-19 and severe COVID-19.
Methods
MEDLINE, Scopus, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, the World Health Organization Global Literature on Coronavirus Disease, and CoronaCentral databases were searched and studies were selected. Independent reviewers selected randomized controlled trials and cohort studies with the outcome of interest. Independent reviewers extracted data, and assessed the risk of bias. Meta-analysis was …
Total citations